Browse Learn
What is biotechnology?
Biotechnology, or biotech, uses living cells and biological processes to make useful products. It helps us develop medicines, improve crops, diagnose diseases, and even make certain foods.
Biotech turns biology into technology.
Scientists learn how living things work and then use that knowledge to solve a practical problem.
1. What is biotechnology?
Biotechnology is the use of living organisms, cells, or parts of cells to create products or improve processes. It is not limited to medicine. Farmers, food makers, and environmental scientists also use biotechnology. Even making yogurt with bacteria is a simple form of biotechnology.
Modern medical biotech goes further. Scientists can study DNA—the instructions inside our cells—and use proteins, antibodies, or modified cells to help treat disease. For example, some modern diabetes medicines are produced using living cells that have been taught to make human proteins.[1]
Healthcare
Medicines, vaccines, diagnostic tests, and treatments made from cells or genes.
Beyond medicine
Better crops, food production, cleaner industrial processes, and environmental applications.
2. How does biotechnology work?
Imagine the body needs a protein but cannot make enough of it. Scientists can identify the DNA instructions for that protein and place them inside a suitable cell, such as a bacterium. The cell then acts like a tiny factory, making the protein. Scientists collect and purify it for use in a medicine.
This approach helped make human insulin using genetically modified bacteria, a major early achievement of the modern biotech industry.[1] Not every biotech treatment is made this way: some use antibodies, genetic instructions, or living human cells.
3. How did biotechnology begin?
People have used living organisms for thousands of years to make bread, cheese, and fermented drinks. But modern biotechnology took shape in the 1970s, when scientists learned how to move DNA between organisms. This new method, called recombinant DNA technology, made it possible to ask cells to produce useful human proteins.[2]
Genentech, founded in 1976, became one of the first modern biotechnology companies. In 1982, the United States approved recombinant human insulin for diabetes. It showed that genetic engineering could produce a real medicine, not just a laboratory experiment.[1]
4. What is the difference between biotech and pharma?
Biotechnology and pharmaceuticals overlap, but they are not exactly the same thing. Biotech describes a set of technologies that use biology. Pharmaceuticals describes medicines and the businesses that develop and sell them. Many pharmaceutical companies use biotechnology, and many biotech companies develop medicines.
People often use “biotech” to describe newer companies working on biological medicines, while “big pharma” describes larger drug companies. That is a business distinction, not a strict scientific rule. A biotech company may make a traditional chemical drug, and a major pharmaceutical company may make complex biologic medicines.[4]
Often made by chemistry
A relatively small molecule can be built through chemical reactions. Many familiar pills work this way.
Often made using cells
A large or complex product, such as an antibody, may require living cells and careful manufacturing.
The more precise drug-science comparison is small-molecule drugs versus biologics, not simply biotech versus pharma. FDA explains how biological products differ from many conventional drugs.[4]
5. How has biotechnology changed over time?
Early biotech focused heavily on making proteins that the human body already produces, such as insulin. Later, scientists developed medicines such as monoclonal antibodies, which can recognize specific targets in the body. Reading human DNA became much easier after the Human Genome Project, completed in 2003.[3]
Today, scientists may try to correct a genetic problem, change how a cell behaves, or help the immune system attack cancer. In other words, biotech has moved from making missing proteins toward changing biological processes themselves. These are powerful tools, but each treatment still needs evidence that its benefits outweigh its risks.[5]
6. What does biotechnology look like in 2026?
Biotechnology in 2026 includes several kinds of medicine. Antibody therapies can block or change signals in the body. RNA medicines can change how cells use genetic instructions. Gene therapies aim to treat disease by adding, replacing, or changing genetic material. Cell therapies use living cells as the treatment itself.
These technologies have moved beyond theory. The FDA maintains a list of approved cell and gene therapy products, including Casgevy, a treatment that uses edited blood-forming cells for certain inherited blood diseases.[5] Still, a promising laboratory idea is not automatically a successful medicine: new treatments must be tested for safety and effectiveness, reviewed by regulators, and monitored after approval.[6]
Block a signal
Think of a key designed to fit one particular lock on a cell or protein.
Change a message
Influence the instructions that cells read when they make proteins.
Change genetic material
Try to address disease using changes to genes or how genes work.
Use living cells
Give patients cells that can perform a useful medical function.
Sources & further reading
Primary institutional sources were selected for accessibility and factual grounding. Links open the original material.
- National Academies / NCBI Bookshelf — “Birth of the Biotechnology Industry”. Early recombinant DNA, Genentech, and human insulin.
- Smithsonian National Museum of American History — “The Birth of Biotech”. Origins of modern genetic engineering.
- National Human Genome Research Institute — Human Genome Project Fact Sheet. Genome sequencing and the 2003 milestone.
- U.S. Food and Drug Administration — What Are Biologics?. Biologics and conventional drugs.
- U.S. Food and Drug Administration — Approved Cellular and Gene Therapy Products. Current examples of regulated therapies.
- U.S. Food and Drug Administration — The Drug Development Process. Testing, regulatory review, and monitoring.
Explore the next topic
Biotechnology is a broad field. These Learn guides are useful next steps for understanding how biotech evidence is read and valued.
Educational content, not investment advice. Terms